Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer重编程T细胞-髓系细胞串扰克服结直肠癌中的免疫抵抗Cell Reports MedicineIF10.62026-05-050OAAI
Defining the determinants of immune response in DNA homologous recombination deficient tumorsJOURNAL OF IMMUNOLOGYIF3.42025-11-010PRE
Pharmacological effects of ex vivo mesenchymal stem cell immunotherapy in patients with acute kidney injury and underlying systemic inflammationSTEM CELLS TRANSLATIONAL MEDICINEIF4.92021-09-2817OAAI
Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune Cells (vol 10, 10142, 2020)SCIENTIFIC REPORTSIF3.92020-09-170OAAI
Mesenchymal Stromal Cell Bioreactor for Ex Vivo Reprogramming of Human Immune CellsSCIENTIFIC REPORTSIF3.92020-06-2326OAAI
Convergence of Cell Pharmacology and Drug DeliverySTEM CELLS TRANSLATIONAL MEDICINEIF4.92019-05-1517OAAI
PHASEI/II INTERIM ANALYSIS OF EXTRACORPOREAL MESENCHYMAL STROMAL CELL THERAPY (SBI-101 THERAPY) IN SUBJECTS WITH ACUTE KIDNEY INJURYCYTOTHERAPYIF3.22019-05-010PREAI